Secondary Logo

Journal Logo

Articles by P. Richard Harrigan

Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches

Lee, Guinevere Q.; Bangsberg, David R.; Mo, Theresa; More

AIDS. 31(17):2345-2354, November 13, 2017.

Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda

Lee, Guinevere Q.; Lachowski, Chris; Cai, Eric; More

AIDS. 30(11):1781-1788, July 17th, 2016.

Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes

Lima, Viviane D.; Reuter, Anja; Harrigan, P. Richard; More

AIDS. 29(14):1871-1882, September 10, 2015.

Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy

Jitratkosol, Marissa H.J.; Sattha, Beheroze; Maan, Evelyn J.; More

AIDS. 26(6):675-683, March 27th, 2012.

HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort

Alexander, Christopher S.; Dong, Winnie; Chan, Keith; More

AIDS. 15(5):601-607, March 30th, 2001.

Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens

Montaner, Julio S. G.; Harrigan, P. Richard; Jahnke, Natalie; More

AIDS. 15(1):61-69, January 5th, 2001.

Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting

Harrigan, P. Richard; Hertogs, Kurt; Verbiest, Werner; More

AIDS. 13(14):1863-1871, October 1st, 1999.

Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users

Alexander, Christopher S.; Dong, Winnie; Schechter, Martin T.; More

AIDS. 13(8):981-985, May 28th, 1999.